Full title: A multi-center, open-label, dose-escalation study to assess the pharmacokinetics of ASA404 in adult cancer patients with impaired hepatic function and with normal hepatic function Cancer type: Various Status: Closed Brief description:   ASA404 is a new anti tumour drug that was developed at Auckland Cancer Society Research Centre and Antisoma and is now … Continue reading ASA404